SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Jeffrey R. Curtis, Khaled Sarsour, Pavel Napalkov, Laurie A. Costa, Kathy L. Schulman, Incidence and complications of interstitial lung disease in users of tocilizumab, rituximab, abatacept and anti-tumor necrosis factor α agents, a retrospective cohort study, Arthritis Research & Therapy, 2015, 17, 1

    CrossRef

  2. 2
    Tsutomu Takeuchi, Nobuyuki Miyasaka, Shinichi Kawai, Naonobu Sugiyama, Hirotoshi Yuasa, Noriaki Yamashita, Noriko Sugiyama, Lorin Craig Wagerle, Bonnie Vlahos, Joseph Wajdula, Pharmacokinetics, efficacy and safety profiles of etanercept monotherapy in Japanese patients with rheumatoid arthritis: review of seven clinical trials, Modern Rheumatology, 2015, 25, 2, 173

    CrossRef

  3. 3
    C. Sharp, N. Dodds, L. Mayers, A.B. Millar, H. Gunawardena, H. Adamali, The role of biologics in treatment of connective tissue disease-associated interstitial lung disease, QJM, 2015, 108, 9, 683

    CrossRef

  4. 4
    Percival D. Sampaio-Barros, Irene E. van der Horst-Bruinsma, Adverse effects of TNF inhibitors in SpA: Are they different from RA?, Best Practice & Research Clinical Rheumatology, 2014, 28, 5, 747

    CrossRef

  5. 5
    Robert W. Hallowell, Maureen R. Horton, Interstitial Lung Disease in Patients with Rheumatoid Arthritis: Spontaneous and Drug Induced, Drugs, 2014, 74, 4, 443

    CrossRef

  6. 6
    Camille Roubille, Boulos Haraoui, Interstitial lung diseases induced or exacerbated by DMARDS and biologic agents in rheumatoid arthritis: A systematic literature review, Seminars in Arthritis and Rheumatism, 2014, 43, 5, 613

    CrossRef

  7. 7
    Joseph D. Feuerstein, Adam S. Cheifetz, Miscellaneous Adverse Events with Biologic Agents (Excludes Infection and Malignancy), Gastroenterology Clinics of North America, 2014, 43, 3, 543

    CrossRef

  8. 8
    Fabiola Atzeni, Luigi Boiardi, Salvatore Sallì, Maurizio Benucci, Piercarlo Sarzi-Puttini, Lung involvement and drug-induced lung disease in patients with rheumatoid arthritis, Expert Review of Clinical Immunology, 2013, 9, 7, 649

    CrossRef

  9. 9
    Benedetta Marigliano, Alessandra Soriano, Domenico Margiotta, Marta Vadacca, Antonella Afeltra, Lung involvement in connective tissue diseases: A comprehensive review and a focus on rheumatoid arthritis, Autoimmunity Reviews, 2013, 12, 11, 1076

    CrossRef

  10. 10
    Lorenzo Cavagna, Sara Monti, Vittorio Grosso, Nicola Boffini, Eva Scorletti, Gloria Crepaldi, Roberto Caporali, The Multifaceted Aspects of Interstitial Lung Disease in Rheumatoid Arthritis, BioMed Research International, 2013, 2013, 1

    CrossRef

  11. 11
    Meghna Jani, Nik Hirani, Eric L. Matteson, William G. Dixon, The safety of biologic therapies in RA-associated interstitial lung disease, Nature Reviews Rheumatology, 2013, 10, 5, 284

    CrossRef